Works matching AU Fein, Luis

Results: 10
    1
    2

    A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study).

    Published in:
    2016
    By:
    • Gómez, Henry L.;
    • Neciosup, Silvia;
    • Tosello, Célia;
    • Mano, Max;
    • Bines, José;
    • Ismael, Gustavo;
    • Santi, Patrícia X.;
    • Pinczowski, Hélio;
    • Nerón, Yeni;
    • Fanelli, Marcello;
    • Fein, Luis;
    • Sampaio, Carlos;
    • Lerzo, Guillermo;
    • Capó, Adolfo;
    • Zarba, Juan J.;
    • Blajman, César;
    • Varela, Mirta S.;
    • Martínez-Mesa, Jeovany;
    • Werutsky, Gustavo;
    • Barrios, Carlos H.
    Publication type:
    journal article
    3
    4
    5
    6

    POLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients with BRAF V600-mutant melanoma with brain metastasis.

    Published in:
    Neuro-Oncology Advances, 2024, v. 6, n. 1, p. 1, doi. 10.1093/noajnl/vdae033
    By:
    • Menzies, Alexander M;
    • Long, Georgina V;
    • Kohn, Amiee;
    • Tawbi, Hussein;
    • Weber, Jeffrey;
    • Flaherty, Keith;
    • McArthur, Grant A;
    • Ascierto, Paolo A;
    • Pfluger, Yanina;
    • Lewis, Karl;
    • Tsai, Katy K;
    • Hamid, Omid;
    • Prenen, Hans;
    • Fein, Luis;
    • Wang, Erjian;
    • Guenzel, Carolin;
    • Zhang, Fan;
    • Kleha, Joseph F;
    • Pietro, Alessandra di;
    • Davies, Michael A
    Publication type:
    Article
    7
    8

    Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate.

    Published in:
    Clinical Drug Investigation, 2023, v. 43, n. 9, p. 699, doi. 10.1007/s40261-023-01294-3
    By:
    • Fein, Luis;
    • Lazaretti, Nicolas;
    • Chuken, Yamil López;
    • Benfield, J. Rogelio González Ramírez;
    • Mano, Max S.;
    • Lobaton, Jose;
    • Korbenfeld, Ernesto;
    • Damian, Fernanda;
    • Lu, Dongrui R.;
    • Mori, Ave;
    • Patyna, Shem J.;
    • Franco, Sandra
    Publication type:
    Article
    9

    Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes.

    Published in:
    Breast Cancer Research & Treatment, 2010, v. 122, n. 2, p. 409, doi. 10.1007/s10549-010-0901-4
    By:
    • Hortobagyi, Gabriel;
    • Gomez, Henry;
    • Li, Rubi;
    • Chung, Hyun-Cheol;
    • Fein, Luis;
    • Chan, Valorie;
    • Jassem, Jacek;
    • Lerzo, Guillermo;
    • Pivot, Xavier;
    • Hurtado de Mendoza, Fernando;
    • Xu, Binghe;
    • Vahdat, Linda;
    • Peck, Ronald;
    • Mukhopadhyay, Pralay;
    • Roché, Henri
    Publication type:
    Article
    10

    SGLT2 inhibition improves PI3Kα inhibitor–induced hyperglycemia: findings from preclinical animal models and from patients in the BYLieve and SOLAR-1 trials.

    Published in:
    Breast Cancer Research & Treatment, 2024, v. 208, n. 1, p. 111, doi. 10.1007/s10549-024-07405-8
    By:
    • Borrego, Manuel Ruiz;
    • Lu, Yen-Shen;
    • Reyes-Cosmelli, Felipe;
    • Park, Yeon Hee;
    • Yamashita, Toshinari;
    • Chiu, Joanne;
    • Airoldi, Mario;
    • Turner, Nicholas;
    • Fein, Luis;
    • Ghaznawi, Farhat;
    • Singh, Jyotika;
    • Pantoja, Kristyn;
    • Schnell, Christian;
    • Akdere, Murat;
    • Chia, Stephen
    Publication type:
    Article